Endoprosthesis Market Intelligence, Prescriptive Research, Execute Growth Opportunities
Market Highlights
The Endoprosthesis
Market is expected to register a CAGR of 11.58% during the forecast
period 2022-2030, to reach USD 45,134.19 million by 2030.
Endoprosthesis is a surgery that involves using an implant
to replace a joint in the body that has lost functionality due to damage or
disease, in part or whole. Degenerative joint disease, fractures, and
malignancies are all common markers for endoprosthesis use. The growth of the
global endoprosthesis is driven by factors such as the increasing prevalence of
osteoarthritis among the geriatric population, technological advancements in endoprosthesis
devices enabling effective treatment, and increasing awareness among
the population. However, adverse effects and high costs associated with
endoprosthesis are likely to restrain the market growth.
Key Players—
Johnson & Johnson Services, Inc.(US), Zimmer Biomet
Holdings Inc.(US), Stryker(US), Smith & Nephew(UK), Corin Ltd (UK),
MedactaInter national SA (Switzerland), Exactech, Inc.(US),
MicroPortOrthopedics, Inc.(US), Baumer S.A. (Switzerland), and B. Braun Melsungen
AG (Germany).
MRFR recognizes the following companies as the key
players in the global Endoprosthesis
Segment Analysis
The global endoprosthesis market is segmented into products,
further categorized into the knee, hip, shoulder, elbow, finger/hand, and
ankle/foot endoprosthesis products. The knee, hip, and shoulder segments are
further segmented into primary replacement, partial replacement, custom-made
replacements, revision replacement, and tumor. The elbow segment is categorized
into total elbow replacement, radial head replacement, tumor, and custom-made
replacements. The finger/hand segment is segmented into the total wrist, PIP,
and MCP finger prosthesis. Lastly, the ankle/foot segment is categorized into
the total ankle and great toe implant segments.
Regional Analysis
The global endoprosthesis market, based on region, has been
divided into North America, South America, Europe, Asia-Pacific, and the Middle
East & Africa.
The North American market accounted for the largest share of
29.57% in 2020 and is expected to increase at a CAGR of 11.26% during the
forecast period. This is due to the rise in prevalence of knee & hip
osteoarthritis among the geriatric population, the presence of key players and
lifestyle diseases, technological developments in healthcare applications, and
increasing adoption of technically advanced healthcare products.
The South American market held a market share of 14.6% in
2020 and is expected to register a CAGR of 10.38%. Factors like inexpensive
treatments, a rise in musculoskeletal diseases, and an increasing geriatric
population will drive the market in the forecast period.
Europe accounted for a market share of 24.59% in 2020 and is
expected to exhibit a CAGR of 12.41% during the forecast period. Factors such
as the increase in the prevalence of joint disorders, improved healthcare
infrastructure in the region, the rising geriatric population, and growing
awareness about the use of prosthetics in orthopedic injuries are propelling
the regional market growth. For instance, according to the Eurostat data
published in 2020, 90.4 million older people aged 65 and above were living in
the EU-27 in 2019.
Asia-Pacific is expected to register the highest growth rate
over the forecast period from 2021to 2027 at a CAGR of 12.78%. Factors like the
growing incidence of osteoarthritis and a booming aging population are
projected to boost the market growth in the region over the forecast period. In
addition, growing expenditure on healthcare infrastructure and rising
affordability of the surgery are likely to drive the region’s market growth.
The Middle East & Africa region accounted for a market
share of 10.93% in 2020. It is expected to have a CAGR of 9.66% in the forecast
period. The market growth is less due to slowly improving economies. However,
factors like the growing aging population and improving healthcare
infrastructure will drive the growth of the endoprosthesis market.
Key Findings of the Study
·
The global endoprosthesis market is estimated to
reach USD 45,134.19 million by 2027 at a CAGR of 11.58% during the assessment
period of 2021to 2027.
·
North America will hold the largest share of the
global endoprosthesis market during the forecast period due to prominent US
players, rising arthritis cases, and technological developments in healthcare
infrastructure.
·
Based on product, the knee segment accounted for
the largest market share and the highest CAGR of 12.73%in 2020.
·
On the basis of the knee, the primary knee
replacement segment held the highest share of 31.85% in 2020.
·
Based on hip, the primary hip replacement
segment held the highest share of 32.08% in 2020.
·
Based on elbow, the total elbow replacement
segment dominated the market with a market share of 35.40%in 2020.
Related Report-
·
Hydrophobic Interaction Chromatography Market Research Report – Forecast
to 2027
·
Periodontal Therapeutic Market Research Report – Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment